Is FEV1 associated with quality of life in children with cystic fibrosis? An original article

被引:0
|
作者
Shirzadi, Rohola [1 ]
Navaei, Safoura [1 ]
Modaresi, Mohammadreza [1 ]
Masiha, Farzad [2 ]
机构
[1] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Resp & Sleep Med Res Ctr, Tehran, Iran
[2] Mazandaran Univ Med Sci, Pediat Infect Dis Res Ctr, Sari, Iran
来源
IMMUNOPATHOLOGIA PERSA | 2020年 / 6卷 / 01期
关键词
Pulmonary function; Cystic fibrosis; Spirometry; Quality of life; LUNG-FUNCTION; WALK TEST; STRESS;
D O I
10.15171/ipp.2020.06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Cystic fibrosis (CF) is a serious genetic life-shortening disease. Quality of life (QoL) measurement related to CF children is a relatively new field of research, which includes the patient's perspective in research and clinical practice. Objectives: This study aimed to evaluate the QoL in children with CF and its association with FEV1 (forced expiratory volume in 1 second). Patients and Methods: This cross-sectional study was carried out on 7-14 years old children with CF attending children's medical center from March 2017 to March 2018. Throat swab cultures and spirometry evaluation was performed for all patients. FEV1 was determined and the 6-min walk test (6MWT) was conducted. The patient's psychological status was assessed using the Persian version of pediatric QoL inventory. ANOVA, t test, and chisquare tests were used for data analysis. Results: Seventy-six subjects with the mean age of 10.49 +/- 3.18 years were studied since 59% of them (n=44) were boys. The mean total QoL was 65.34 +/- 17.73. Patients with lower pulmonary function had a lower QoL. There was a significant association between FEV1 and school and emotional functioning (P = 0 .005 and P=0.002, respectively). A significant association was found between SPO2 (peripheral capillary oxygen saturation) reduction after 6MWT and FEV1 decline (P = 0.001). Additionally, a significant association was detected between FEV1 and the distance walked during 6MWT (P = 0.030). Conclusion: Regarding the association between pulmonary function and QoL in CF patients and lower QoL score in our study, the importance of assessing pulmonary function in these patients should not be neglected.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Recurrent exacerbations affect FEV1 decline in adult patients with cystic fibrosis
    Amadori, Anna
    Antonelli, Andrea
    Balteri, Ilaria
    Schreiber, Anja
    Bugiani, Massimiliano
    De Rose, Virginia
    RESPIRATORY MEDICINE, 2009, 103 (03) : 407 - 413
  • [22] Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries
    Kim, Sang-Ook
    Corey, Mary
    Stephenson, Anne L.
    Strug, Lisa J.
    THORAX, 2018, 73 (05) : 446 - 450
  • [23] The predictive role of lung clearance index on FEV1 decline in cystic fibrosis
    Ozsezen, Beste
    Yalcin, Ebru
    Emiralioglu, Nagehan
    Unlu, Hande Konsuk
    Tural, Dilber Ademhan
    Caka, Canan
    Sunman, Birce
    Dogru, Deniz
    Ozcelik, Ugur
    Kiper, Nural
    TURKISH JOURNAL OF PEDIATRICS, 2024, 66 (03) : 297 - 308
  • [24] Return of FEV1 After Pulmonary Exacerbation in Children With Cystic Fibrosis (vol 45, pg 127, 2010)
    Sanders, Don B.
    Hoffman, Lucas R.
    Emerson, Julia
    Gibson, Ronald L.
    Rosenfeld, Margaret
    Redding, Gregory J.
    Goss, Christopher H.
    PEDIATRIC PULMONOLOGY, 2010, 45 (05) : 521 - 523
  • [25] Relationship of Antibiotic Treatment to Recovery after Acute FEV1 Decline in Children with Cystic Fibrosis
    Morgan, Wayne J.
    Wagener, Jeffrey S.
    Pasta, David J.
    Millar, Stefanie J.
    VanDevanter, Donald R.
    Konstan, Michael W.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (06) : 937 - 942
  • [26] Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher
    Szczesniak, Rhonda
    Heltshe, Sonya L.
    Stanojevic, Sanja
    Mayer-Hamblett, Nicole
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (03) : 318 - 326
  • [27] Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study
    Taylor-Robinson, David
    Whitehead, Margaret
    Diderichsen, Finn
    Olesen, Hanne Vebert
    Pressler, Tania
    Smyth, Rosalind L.
    Diggle, Peter
    THORAX, 2012, 67 (10) : 860 - 866
  • [28] Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis
    Sanders, Don B.
    Emerson, Julia
    Ren, Clement L.
    Schechter, Michael S.
    Gibson, Ronald L.
    Morgan, Wayne
    Rosenfeld, Margaret
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (08) : 1170 - 1176
  • [29] Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany
    Dittrich, A. Susanne
    Dumke, Markus
    Kapl, Ferdinand
    Schneider, Philipp
    Wege, Sabine
    Graeber, Simon
    Stahl, Mirjam
    Herth, Felix J.
    Naehrlich, Lutz
    Mall, Marcus A.
    Sommburg, Olaf
    RESPIRATION, 2023, 102 (05) : 351 - 360
  • [30] FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis
    Robinson, W
    Waltz, DA
    PEDIATRIC PULMONOLOGY, 2000, 30 (03) : 198 - 202